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TT is known that the incidence of blood-borne tumour metastases mav be
influenced by many factors and by several experimental procedures (Baserga and
Baum, 1955; Wood, 1958). One of these determining factors is the number of
embolic tumor cells circulating in the blood streain. Zeidman, McCutcheon and
Coman (1950) showed that the number of lung metastases in mice was roughly
proportional to the number oftumor cells injected intravenously. More recently,
the frequent finding of tumor cells in random samples of venous blood from
tumor-bearing patients (Engell, 1955 ; Sandbert et al., 1958 ; Pruitt, Hilberg and
Kaiser, 1958) has indicated that a relatively large number of tumour cells may
actually be present at any given time in the blood stream of these patients.
These observations have prompted us to expand the investigation of Zeidman and
co-workers to cover a wider range ofthe dose-response curve, with the objective of
establishing a quantitative relationship between the number of embolic tumour
cells and the incidence of metastases. Because of the quantitative conditions of
the present experiment we thought it worthwhile to investigate at the same time
otherfactors that have been said to affect the incidence ofblood-borne metastases,
such as the sex of the animal (Poel, 1957), the simultaneous injeetion of killed
tumor cells (Donaldson and Mitchell, 1959) or the pre-treatment with viable
tumor cells (Hackmann, 1938) as well as the response of the reticulo-endothelial
system to the presence of metastases (Foulds, 1932 ; Druckrey et al., 1939 ;
'"Iartmaii, 1959). For these purposes, different doses of viable Ehrlicli ascites
tunior cells -%i-ere injected into the tail vein of mice of both sexes, two groups being
u,,-.,,ed to study the effects of the simultaneous injection of killed tumor cells or
previous injectioii of viable tumor cells. The incidence and nun'lber of lung
metastases in each group was determined by actual count, and the weights of the
lungs, spleen, liver and kidneys -%A-ere used to establish a quantitative iiidex of the
response of the reticulo-endothelial system to the presence of tumor metastases.
.MATERIALS AND METHODS
C, xAF1 mice, of both sexes and 4-6 months old which had beeii bred in the
Department of Pathology of Northwestern University Aledical School by Dr.
-'A"illard T. Hill, were kept in plastic cages in air-conditioned quarters, and given
Rockland mouse diet and water ad libitum.
The tumor was Ehrlich ascites tumor, a subline of which has been propagated
in this Laboratory for 5 years by weekly intraperitoneal injections to healthy174 R. BASERGA, P. B. PUTONG, S. TYLER AND W. B. WARTMAN
carriers. Suspensions of viable tumor cells were prepared as follows: the peri-
toneal fluid was aspirated 7-10 days after inoculation and centrifuged at 3000
r.p.m. for 10 minutes, the supernatant discarded and the tumor cens resuspended
in sterile isotonic saline in the desired dilution. The tumour cells were counted
in a hemocytometer, 5 to 10 counts being used for each dilution. Due to the
difficulties involved in obtaining round numbers of tumor cells, suspensions that
were as near the desired dose level as possible were used. The number of viable
cells in thesuspensions as determinedby Schreck's method (1936), ranged between
93 and 98 per cent.
Suspensions ofnon-viable tumor cells wereprepared as follows: 7-10-days-old
Ehrlich ascites tumor was aspirated from theperitoneal cavity ofhealthy carriers,
placed in glass tubes, centrifuged at 3000 r.p.m. for 10 minutes and the super-
natant discarded. Ten per cent buffered formalin was added to thepacked tumor
cells in a ratio of 7 : I and the suspension was placed in a refrigerator at 4' C. for
12-18 hours. The formalinized cells were then centrifuged and washed 4 times
with normal saline solution and finally resuspended in sterile isotonic saline
in the desired dilution. Viabilitv counts showed 100 per cent non-viable cells.
Only female mice were used to estabhsh thedose-response curve. The number
of tumor cells injected and the number of animals in each group are shown in
Table 1. For the second part of the experiment, on the incidence of metastases
TABLE I.-Incidence of Meta8tases in CAF, Female Mice Injected Intravenously
with Ehrlich Ascitei Tumor Cells
Number of tumor cells % of mice with Number of Number of
injected ± S N metastases metastases metastasesper mouse
None 25 0.0 ol 0.000
905±170 19 27 10.5 7 4 2 2 0.105 0- 074 14,390±700 8 0.0 0 0.000
93,200±6,800 16 25- 0 4 0- 250
382,000±80,000 18 33- 3 8 0-444
597,000±90,000 44 52- 3 37 0- 864
747,000±110,000 26 80- 8 58 2- 192
928,000±76,000 16 100.0 97 6- 062
1,180,000±88,000 8 100.0 114 14- 250
1,654,000±140,000 20 100-0 815 40- 750
1,885,000±350,000 I0 100.0 >200
4,526,000±180,000 14 100.0 >200
6,750,000±120,000 II 100.0 >200
8,696,000±430,000 6 100- 0 >200
S = standard deviation.
N = number of mice.
in mice p'reviously treated with viable or non-viable tumor cells, only male mice
were used. The number of tumor cells injected and the number of animals in
each group are shown in Table 111. All injections, either of viable or non-viable
cells, were made into the tail vein, using a 27-gauge needle and a calibrated
syringe. About half the injections resulted in local growths at the injection site
in the tail or at the root ofthe tail. All animals that showed theslightest evidence
of local growths were discarded, and were not included in the computations.
Except when otherwise stated, the mice were sacrificed by cervical dislocation
30 days after the injection of tumor cells. The body weight and the weights ofNUMBER OF EMBOLIC TUMOR CELLS AND METASTASES 175
the lungs, liver, spleen and left kidney were determined for each animal. The
lungs were examined and the number of grossly visible metastases counted by
two different observers. Precise counts were not possible when the number of
metastases in both lungs was above 200.
The number of tumor cells in a given weight ofpacked Ehrlich ascites tumor
was determined as follows: 5 ml. of tumor cell suspension, from 8-day-old
peritoneal growths were measured in a calibrated pipette and the number of cells
per ml. was determined as usual with a hemocytometer. After centrifuging and
discarding the supernatant, the packed tumor cells were weighed on an analytical
balance, the weight obtained being taken as the weight of the number of cells
contained in 5 ml. oftumorsuspension. Theprocedure wasrepeated on 5 different
animals, and the results were averaged.
RESULTS
1. Dose-response relationships
Table I shows the incidence oflung metastases in CAF, female mice following
intravenous injection of Ehrlich ascites tumor cells. Animals alive on the 30th
day of the experiment were sacrificed. Other animals were autopsied on the day
of death. All animals of the groups receiving less than 1,180,000 cells were alive
on the 30thday, and the last 5 groups had mean survival timesequal to 26, 20, 16,
15 and 14 days respectively. The incidence of metastases below 100 per cent
when plotted on probability paper, was linearly related to dose (Fig. 1). This
indicates that the distribution of susceptibilities to Ehrhch ascites tumor cells is
approximately normal with least square estimates of mean and standard deviation
equal to 512,000 and 394,000 cellsrespectively. Therelationship between average
number ofmetastases per mouse anddose, forgroups in which a tumor count could
be made, is shown in Fig. 2 and is definitely nonlinear. However, the difference
between the trend seen at small doses and that characterizing large dose groups
suggests that at least two processes may influence thepattern seen inFig. 2. It is
of interest to note that for doses equal to or less than 600,000 cells, the relation
between variables is essentially linear ; while for doses exceeding 600,000 cells
the pattern ofpoints accelerates even faster than a simple exponential function.
Also for doses not exceeding 600,000 cells the group incidence predicted, based
on Poisson expectations with the observed number of metastases per mouse as
mean value, agrees closely with the observed incidence within groups. On the
contrary, for doses above 600,000 cells, the expectations greatly deviate from the
observed.
Since the lung is the principal site of establishment and growth of Ehrlich
ascites tumor cells injected intravenously, a weight change in this organ should
reflect the severity ofthe insult sustained by the organism as the dose is increased
and provide a means of interpolation between the experimentally controlled
dosages. The increase in lung weight with injected dose (Table 11) was found to
be a moderately sensitive indicator. Since the average weight of the lungs for
groups injected with 382'000 cells or less seemed to vary about the mean of the
controls in a random fashion, the mean weight of the lungs of the controls was
taken as the weighted average of these groups and was found to be 173-2 mg.
A linear relationship between mean lung weight as per cent of the control value
and dose exists over a range ofdosesextending from 600,000 cells toapproximately176 R. BASERGA, P. B. PUTONG, S. TYLER AND W. B. WARTMAN
2 million cells (Fig. 3). Lung weights for injected doses above this range tend
toward an asymptotic or probably an anatomical limiting value which is in the
neighborhood of 700 mg. Within this range of doses, the magnitude of the slope
of the least square line indicates that the lung weight increases at a constant
rate of 0-165 grams per 1000 cells injected. The equation of the least square
Iiiie is :
L 3-55 + 0-165D) 6 x 102D 2 x 103 (1)
AA'Iiere L is the, mean lung weight in per cent of the control value aiid D is the
doseiD thousands ofinjected cells.
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FiG. I.-Probit transforination of the dose-incidence curve. Per cent of animals with lung metastases, CAF, fei-nale i-nice injected intravenously with Ehrlich ascites tumor cells. Slope
= 0-002534 ± 0-000498 ; ED,50
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Althotigh the dependence betweenlungweight and mean number ofmetastases
per animal does not allow a simple explanation, an empirically derived functional
relationship between these variables is presented in Fig. 4. A log-log plot of
the variables shows a linear relationship between their log transforms. This
relationship at doses exceeding 382,000 cells is expressed by the power law
-11 = 3-689(10-10) P. 622 (2)
NNI-here M is the mean number of metastases per animal and L is the mean lung weight in per cent ofthe control weight. From equations (1) and (2), an empirical expression of the dependence between number of metastases and dose can readily be determined.I .
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FIC.- 2.-Relationship between average number oflung metastases per mouse and number of
tumor cells injected. CAY, female mice injected intravenously with Ehrlich ascites tumor
cells.
TABLE H.-Mean Weight-8 of Lungs, Spleen, Liver and Left Kidney of CAF,
Female Mice Injected Intravenou-sly with Ehrlich Ascites Tumor Cell8
Kidney
weight
-111--.
n x SZF
25 174 2
19 165 4
8 152 4
16 173 3
18 159 3
23 181 4
10 191 5
10 185 3
19 183 4
6 175 7
4 189 12
Body weight Lungsweight
r---111-.
n Y sx n 1 S.T
25 26-8 0-3 25 182 2
19 25-9 0-5 19181 4
8 25- 8 1-2 8 161 4
16 27-9 0-4 16 178 5
18 26-0 0-3 18 154 4
44 26-5 0-3 44 182 4
25 27-1 0-6 26 225 11
16 26-2 0-5 16 277 11
8 24-6 1-6 8 344 41
20 25-6 0-4 10 451 17
10 25-6 1-0 10 567 36
14 24-7 0-8 14 572 34
11 25-1 0-8 11 665 36
6 25-6 0-9 6 687 48
14 26-9 0-5 14 205 7
Liverweight
n X S3.
14 1529 61
19 1301 29
8 1334 33
8 1472 43
18 1274 38
16 1539 80
9 1485 65
17 1656 41
6 1895 46
2 1925 145
Spleenweight
n Sx-
25 127 4
19 132 3
8 124 7
16 159 7
18 125 12
42 158 6
23 229 27
16 224 12
7 241 23
19 327 12
6 338 40
6 361 14
3 327 12
22 504 23
Number oftumor cells
injected
None
905
14,390
93,200
382,000
597,000
747,000
928,000
1,180,000
1,654,000
1,885,000
4,526,000
6,750,000
8,696,000
Subq. injection
n = number of measures included in mean.
X = mean, in g. for body weight, in mg. for lungs, spleen, liver and kidney. Si. = standard error of the mean.
Subq. injection : a group ofmice withhuge tumorgrowths at the root ofthe tail.178 R. BASERGA, P. B. PUTONG, S. TYLER AND W. B. WARTMAN
2. Response of the reticulo-endothelial system
Eventhough not a single metastasis was found, eithergrossly orhistologically,
in any organ except the lung, a significant response to the presence of tumor
cells was noted in the spleen. The weight of the spleen highly correlates with
number of tumor cellsinjected (TableII). In the liver the correlation is partially
obscured by variations related to the body weight while in the kidney, a statisti-
cally significant trend between weight and dose is not present in the sample.
Spleen weight and dose are linearly i-elated (Fig. .), and thus, by equation 1,
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FIG. 3.-Lung andspleenweights versus dose in CAF, female miceinjectedintravenously with
Ehrlich ascites tumor cefls. Weight of control lungs : 173-2 mg.; slope
= 0
-1651 ± 0-0094,
intercept 3-55 ± 11-88. Weight of control spleen: 133-6 mg.; slope
= 0-0962 ± 0-0137,
intercept
= 77-28 ± 17-17.
a straight line relationship between the weights ofthe spleen andlungs is implied.
In those mice in which animproperintravenousinjection resulted in ahugegrowth
at the root of the tail (Table II), the weight of the spleen was, on the average,
3-7 times the weight of controls. This indicates that the spleen may respond to
the presence of tumor cells regardless of the site of tumor growth.
3. The results in male mice
These are shown in Table 111, fro-M which it is apparent that the incidence
of metastases in male mice is considerably lower than in female mice, the 5 per
cent critical level being used as a measure of significance. It will also be noted
that when killed tumor cells are injected simultaneously with viable cells, the
incidence oflung metastases in male mice increases.179 NUMBER OF EMBOLIC TUMOR CELLS AND METASTASES
When male mice, areinjected, 80 days apart, with two similar doses of viable
tumor ceRs, the incidence oflung metastases is about twice that observed in mice
injected with a single dose. This seems to indicate that previous treatment
with viable tumor cells does not alter the response of the host to a ssecond
injection of viable tumor ceUs.
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4. The estimated number of tumor cell8surviving at the 8ite of arrest
With theprocedure outhned in Methods andMaterials, it was found that 1 ml.
of EAT contained on the average, 139,84 x 106 cells, and that after discarding
the supernatant, this number ofpacked ceRs weighed 278 mg. (mean of 5 trials).
This meant that I mg. ofpacked EAT cells contained an average of 503,000 cells.
Determinations of the percentage dry weight of the lungs showed that there was
little difference between the controllungs (I9 per centdryweight) and the heaviest
lungs filled with tumor (I8 per centdryweight). As the meanweight ofthelungs180 R. BASERGA, P. B. PUTONG, S. TYLER AND W. B. WARTMAN
ofCAF1 female mice was found to be 173-2 mg., any increase inlungweight above
this figure willgive arough approximation ofthe number of tumor cells present in
the lungs. Parallel studies using tritiated thymidine (Baserga, Kisieleski and
Halvorsen, 1960) have shown that EAT cells injected intravenously in CAF,
female mice grow without a latentperiod, at a doubling time of 20 hours, and with
100 per cent of the cells dividing every 20 hours. It is then possible to calculate
from these data the approximate number of tumor cells injected that actually
survived at the site ofarrest anddeveloped into a tumor metastasis. This may be
expressed by the equation
No = Nt (3)
2x
where No is the number of surviving tumor cells at the time of injection, Nt is
the number of tumor cells calculated from thelungweight, and x is the number of
doubling times between injection and death. Calculations have been performed
for the last 6 groups and the results are shown in Table IV. These indicate that
the number ofinjected tumor cells surviving at the site of arrest is less than one
in one thousand.
DISCUSSION
The advantages of using ascites cell suspensions in the study of blood-borne
metastases have been pointed out in 1936 by Warren and Gates, and, more
recently by Ambrus et al. (1956). The advantages are mainly three, i.e. most of
the tumor cells areviable, little or no stroma isinjected with the tumorcells, and it
is possible to reduce to a minimum the contamination with cellular debris which is
unavoidable witb minced tumor tissue. These advantages are particularly
important in quantitative studies as shown in the present experiment (Table 111),
in which the simultaneous injection ofkilled tumor cells increased the incidence of
lung metastases produced by the intravenous injection of viable tumor cells.
Although the technique of intravenous injection of tumor cells still remains
an artificial procedure when compared to the observation of spontaneous blood-
borne metastases (Baserga and Shubik, 1955), it should be noted that according
to Wallace (1956), metastases from intravenously injected cells can be obtained
only with those tumors that are also capable of spontaneous metastases. With
these qualifications, the following considerations may be made.
1. The dose-revon8e relation8hip
When suspensions of EAT cells are injected intravenously in CAF, mice, in
dosesranging from as few as 905 cells to as many as 8-7XI06cells, the incidence of
lung metastases increases as previously pointed out by Zeidman et al. (1950),
with increasing doses. The relationship between dose and mean number of
metastases, however, is linear only up to a dose of 600,000 cells, but for doses
exceeding 600,000 cells the relationship deviates from linearity and accelerates
even faster than a simple exponential function. As the tumor cell suspensions
used in the present experiments were all prepared, by dilution, from an original
pool, it must be assumed that the tumor cell population had a constant per cent
composition in the various doses. Then, the changing slope of the dose-response
curve indicates that the establishment of a metastatic growth does not depend
solely on the presence of favored cells capable of survival at the site of arrest,181 NUMBER OF EMBOLIC TUMOR CELLS AND METASTASES
but that, at least with doses exceeding 600,000 cells, other factors besides the
composition ofthe tumor cell population must be-operating. A possible explana-
tion may be found in the experiments of Kaziwara (1954), who, by employing
small doses of cells inintraperitonealinocula, was able to transform ahyperdiploid
Ehrlich tumor line into a near-tetraploid strain. Small doses then may have
the effect ofselecting only a few favored cells, whereas, withlarger doses, different
clones of cells may survive at the site of arrest. In such a case, our results would
not necessarily be at variance with the findings of Rabotti (1959), who claimed
that metastas.-IS differ from primary growths by having a higher number of
polyploid cells.
It is interesting to compare our results with those obtained by Warner and
James (1959), who studied the dose-response relationship of EAT cells injected intraperitoneally. They found too that the dose-response curve departed from
exponentiality, and that the results could be best summarized by plotting the
distribution of sensitivities of mice against the dose, as we have done in Fig. 1.
By comparing the two distributions ofsensitivities, it would appear that whereas
850 cells are required wheninjectedintraperitoneally toproduce tumorgrowths in
50 per cent ofthe animals, a mean number of 512,000 cells must be injected intra-
venously to obtain the same percentage incidence oflung metastases. As doses
increase, however, the differences seem to disappear, andapproxiinately 1,000,000
cells are requited to produce a 100 per cent incidence of either lung metastases
or peritoneal growths.
Fiom the present data, it may also be stated that, at doses exceeding 382,000
cells, a linear relationship exists between the log transforms of lung weight in
percent of control weight and mean number of metastases, so that the increasse
in lung weight may be used as an indicator of the mean number of metastases.
This is further confirmed by the linear relationship existing between number of
tumor cells injected and per cent increase oflung weight.
2. The re8ponse of the reticulo-endothelialsy8tem
Several authors, in the past, have suggested that the reticulo-endothelial
systemparticipates in the process ofmetastaticgrowth. Foulds' (1932) found that
the incidence of metastases in the lungs, liver and spleen from Brown-Pearce
tumors increased considerably when the rabbits had been previously injected with trypan blue. Brouwer (1938) obtained similar results with a single injection
of I c.c. of Thorotrast, but when using higher doses ofThorotrast,
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show any increase in susceptibility. The increase in the incidence of metastases
brought about by whole-body irradiation of the animal host (Cirio and Balestra,
1930 ; Flaks and Grynkraut, 1934) has also been attributed to the depressing action of irradiation upon the reticulo-endothelial system, and similar view's were
expressed to explain the favorable action of cortisone on metastases (Pomeroy, 1954). Conversely, stimulation of the reticulo-endothelial system by subcutan-
eous injections of carotin was held to be responsible for the inhibition ofgrowth of two different transplantable rat tumors, the Flexner-Jobling carcinoma and
the Jensen sarcoma (Stern and Willheim, 1935). The present data definitely indicate a response of the reticulo-endothelial system, in the form ofhyperplasia to the presence of tumor cells in the animal host. In fact, the linear correlation
between the spleen weights and the lung weights even suggests that the weight182 R. BASERGA, P. B. PUTONG, S. TYLER AND W. B. WARTMAN
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of the spleen may be used as an indicator of the amount of tumor present in the
host. Whether thehyperplasia ofthe reticulo-endothelial system can beregarded
as favorable to the host or not, our data do not indicate.
3. The re-sult-s obtained in male mice
We have already mentioned that the simultaneous injection of killed tumor
cells increases the incidence of metastases and that the pre-treatment of mice
with viable tumor cells does not have any influence on the number of metastases
induced by a subsequentinjection ofviable tumor cells. Perhaps of more interest
is the striking difference in the incidence of metastases, after intravenous in-
jection of EAT cells, between male and female CAF1 mice. A high incidence of
metastases from mammary carcinomas has been reported in estrogen-treated
rats (Nelson, 1944). Poel (1957) has found that theincidenceoflymph node meta-
stases from chemically induced skin tumors was higher in female than in male
mice. To bring out these differences, it is probably necessary to use relatively
small doses, as previously suggested by Gross (1942), who had found sex differ-
ences in the response to the subcutaneous or intraperitoneal inoculation of a
transplantable sarcoma in mice, only when using small doses. These results
should not be construed, however, as implicating ahigher susceptibility offemales
to metastases in general, as the reason for the difference may well reside in the
particular tumor. The results show, however, the advantages of intravenous
injections ofrelatively small doses ofcells intheinvestigation ofthevarious factors
that influence the incidence of blood-borne metastases (Wood, 1958).
4. The number of tumor ce118 8urviviiig at the 8iteof arre,3t
It has been known for a long time that the majority of tumor cell emboli fail
to survive at the site of arrest (Goldmann, 1897 ; Iwasaki, 1915 ; Zeidman et al.,
1950), and recent experiments in this Laboratory using tritiated thymidine to
label injected tumor cells showed that the percentage of Ehrlich ascites tumor
cells that survive at the site of arrest is not above 8 per thousand (Baserga et al.,
1960). Calculations based on the present experiments (Table IV) indicate that
the 8 per thousandfigure should be revised downward, and that, in allprobability, at least with EAT, each metastasis originates from a single tumor cell.
The data used in these calculations are not all of the same accuiacy. The
doubling time of EAT, 20 hours, and therefore the number of doubling times in
each Lyrou-D. are known with considerable precision, and the number of tumor
cell per mg. of packed tumor cells can be considered reasonably accurate, the
standard deviation of the count not exceeding 10 per cent. The least precise of
the data is the actual number of tumor cells present in the lungs, which is based
on the difference from the control weight, that is, on the assumption that the
amount of normal lung tissue remains constant. Actually, normal lung tissue is
in part replaced by tumor tissue especially when the number of metastases is
high. As we have used the lung weight of normal animals as the base line, the
actual amount of tumor present in the lungs, either expressed in weight or in
number of tumor cells, must then be revised upward from the figures given in
Table IV. The difference, however, cannot be more than 25 per cent, and the
resulting corrections in the number of tumor cells surviving at the site of arrest
would not change the two conclusions that can be drawn from these calculations,
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i.e., that the number of surviving cells is in the order of one or less per thousand
and that most of the metastatic growths originate from single cells.
SUMMARY
The dose-response relationship between the number of intravenously injected
tumor cells and the number of lung metastases was investigated in CAF1 mice
using suspensions of viable Ehrlich ascites tumor cells. The correlation was
linear for doses up to 600,000 cells, but with higher doses the relation between
variables increased even faster than a simple exponential function, thus suggesting
a two-fold mechanism in the establishment of tumor metastases. The increase
in lung weight, for doses exceeding 382,000 cells, was linearly correlated to the
number of injected cells, and its log transforms were linearly correlated to the
logarithms ofthe mean number ofmetastases. At equal dose levels, the incidence
of metastases was much higher in female than in male mice, and the incidence in
males was also increased by the simultaneous injection of killed tumor cells.
Previous treatment with viable tumor cells did not alter the response ofthe host to
the subsequent injection ofa second dose ofviable tumor cells. The weight ofthe
spleen was linearly correlated to the weight of the lungs, thus suggesting a
quantitative response of the reticulo-endothelial system to the presence of tumor
in the lung.
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